In congenital PAVF, 70% of patients have a history of hereditary hemorrhagic telangiectasia (HHT) which is caused by mutations in Endoglin (HHT1) and ALK1 (HHT2) [2]. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.